Παρασκευή 14 Δεκεμβρίου 2018
hand-foot syndrome due to paclitaxel: A rare case report p. 284 Pritam S Kataria, Pradip P Kendre, Apurva A Patel, Nahush Tahiliani, Vijay Bhargav, Honey Parekh DOI:10.4103/ijp.IJP_547_17 Hand-foot syndrome (HFS) is a relatively frequent adverse reaction to certain anticancer drugs. HFS is a type of dermatitis which has been most commonly described with 5-fluorouracil and capecitabine. However, HFS with paclitaxel is rare and has been reported sparingly in the literature. A 52-year-old male patient with recurrent carcinoma of the buccal mucosa was started on palliative chemotherapy regimen, injection paclitaxel (175 mg/m2) in combination with injection carboplatin. On post-chemotherapy day 13, the patient started developing pain, dysesthesia followed by bullae formation, and desquamation over palms and soles. Clinically, the patient had Grade 3 HFS characterized by symmetrical, tender skin lesions over the dorsal aspect of palms, and soles with desquamation necessitating interrupti
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Champion EMS is currently seeking a Communications Center Manager. Champion EMS is based out of Longview, Texas, serving the East Texas area...
-
from EMS via xlomafota13 on Inoreader http://ift.tt/2sbML2K
-
from EMS via xlomafota13 on Inoreader http://ift.tt/2sbML2K
-
from EMS via xlomafota13 on Inoreader http://ift.tt/2sbML2K
-
from EMS via xlomafota13 on Inoreader http://ift.tt/2sbML2K
-
Remove ads BioMed Research International Validity and Reliability of the Polish Adaptation of the CHAMPS Physical Activity Questionnaire Th...
-
If you’re attacked on the job, be mentally prepared, physically ready, press savvy, and able to justify your actions in court from EMS via...
-
How the activity of natural enemies changes the structure and metabolism of the nutritive tissue in galls? Evidence from the Palaeomystella ...
-
The Cleveland Clinic shows how the Mobile Stroke Unit by Excellance saves brain function and lives. from EMS via xlomafota13 on Inoreader ...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου